| Derek Richard St Louis, MD | |
|
221 Michigan St Ne Ste 402, Grand Rapids, MI 49503-2538 | |
| (616) 391-1929 | |
| (616) 391-3130 |
| Full Name | Derek Richard St Louis |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 221 Michigan St Ne Ste 402, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467947762 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301115571 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Derek Richard St Louis, MD 221 Michigan St Ne Ste 402, Grand Rapids, MI 49503-2538 Ph: (616) 391-1929 | Derek Richard St Louis, MD 221 Michigan St Ne Ste 402, Grand Rapids, MI 49503-2538 Ph: (616) 391-1929 |
News Archive
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).
The world's food is still far too salty and too many countries are still ignoring the World Health Organisation's (WHO) guidelines on what should be a healthy level of salt in our daily diet according to Professor Franco Cappuccio of the University of Warwick's Warwick Medical School.
Crigler-Najjar syndrome affects about one in a million people at birth. Because of a defective gene, these individuals lack an essential enzyme in their liver to eliminate bilirubin, a toxic bile pigment that accumulates in all body tissues causing jaundice and potentially leading to irreversible and lethal neurological damage.
The development of a wearable to detect early Alzheimer's and other neurodegenerative diseases years before symptoms show has taken a step closer to reality today, as UK charity Alzheimer's Research UK announces a partnership with Boston University that will see the first digital data flowing into its global Early Detection of Neurodegenerative diseases (EDoN) initiative.
› Verified 9 days ago
Dr. Jon R Henke, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Geoffrey M. Remes, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Jan L Mourelatos, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-361-5828 | |
Dr. Brendan Michael Banyon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 | |
Dr. Joseph J Junewick, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Keith Alan Morrow, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Dr. Andrew Kent Moriarity, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 |